For example, transformed small cell lung cancer (SCLC) diverges from its non-transformed EGFR-mutant adenocarcinoma precursors by lacking EGFR expression, thereby rendering them resistant to EGFR inhibitors [216]. The gene discussed is EGFR; the disease is adenocarcinoma.